To see effect of darvi seka and jalaukavcharan in managment of praklinnavartma

ROLE OF DARVISEKA AND JALAUKAVCHARANA IN THE MANAGMENT OF PRAKLINNAVARTMA w.s.r TO ANTERIOR BLEPHARITIS A CLINICAL STUDY

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/06/014585

Enrollment

Registered

2018-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients Diagnosed with Praklinnavartma

Interventions

Intervention1: Darvi Seka : Berberis Aristata Mal depuratum Method Powder of Darvi mixed with 16 time water (1(50gm) part Dravya+16(800ml)part water) and boiled in slow temperature till it become 1/8

Eligibility

Inclusion criteria

Inclusion criteria: Patient presenting with signs and symptoms of Praklinnavartma and anterior Blepharitis. Age â?? 10yr-50yr. Sex â?? either sex

Exclusion criteria

Exclusion criteria: Patient having diseases like corneal ulcer, dacryocystitis, dry eye, lagophthalmos, infective conjunctivitis etc. Patients suffering from specific eyelid disorders like ectropion, entropion, trichiasis, tumor, carcinoma, skin allergies. Systemic diseases like- DM, HTN. HIV positive patients Patient having Hb less than 10 gm%

Design outcomes

Primary

Measure	Time frame
to study in detail with the prevalence etiopathogenesis clinical features complications of Praklinnavartma (Anterior Blepharitis)and its management By Darvi SekaTimepoint: to study in detail with the prevalence etiopathogenesis clinical features complications of Praklinnavartma (Anterior Blepharitis)and its management By Darvi Seka time 15 days of therapy of Darvi Seka and Jalaukavcharana 2 sitting in 15 days therapy	—

Measure

Time frame

to study in detail with the prevalence etiopathogenesis clinical features complications of Praklinnavartma (Anterior Blepharitis)and its management By Darvi SekaTimepoint: to study in detail with the prevalence etiopathogenesis clinical features complications of Praklinnavartma (Anterior Blepharitis)and its management By Darvi Seka time 15 days of therapy of Darvi Seka and Jalaukavcharana 2 sitting in 15 days therapy

—

Secondary

Measure	Time frame
To evaluate clinical efficacy of jalaukavcharana followed by Seka in management of Praklinna vartma (Anterior Blepharitis)Timepoint: 15 Days	—

Countries

India

Contacts

Public ContactDR KANCHAN CHAUCHAN

rishikul campus haridwar

drkanchanchauhan1@gmail.com9568196489

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026